19th February 2022 | Pharma Updates
Bharat Biotech Plans to Launch Two More Vaccines
The drug company may introduce two other Covid vaccines very soon in the market.
Durex is now the second-largest condom brand in India
The brand significantly expanded distribution by 61% compared to 2019. Last year, it registered market share gains of 210 basis points.
FDA Clears Freezor Cardiac Catheters
According to Medtronic, Freezor and Freezor Xtra are the only ablation catheters to treat kids with Atrioventricular Nodal Reentrant Tachycardia.
Veklury Receives FDA Nod
The drug is the generic version of Remdesivir.
Novavax vaccine Wins Approval In Canada
It is the first protein-based vaccine to be approved for use in individuals 18 years of age and older in Canada.
FDA Okays InfraScan's Handheld Brain Bleed Detector for kids
The medical device uses near-infrared technology to detect symptoms of a hematoma in children.
Recipharm Purchases Arranta Bio and Vibalogics
Sweden-based CDMO company is now in a better position to offer ATMPs.
Suanfarma buys Monteloede
Suanfarma has bought Monteloeder, a firm with around 25 years of experience developing botanical ingredients.
Sandoz Presents Generic Revlimid
Germany-based drugmaker Stada Arzneimittel also has introduced a generic version of Revlimid in Europe.
European Commission Okays Saphenlo
AstraZeneca’s Saphenlo is indicated for the treatment of patients with moderateto-severe active autoantibody-positive systemic lupus erythematosus.
